BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Hosaka T, Kawamura Y, Yatsuji H, Hirakawa M. Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus. J Med Virol. 2010;82:390-395. [PMID: 20087925 DOI: 10.1002/jmv.21691] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol. 2013;58:184-189. [PMID: 22871501 DOI: 10.1016/j.jhep.2012.07.026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
2 Dong HV, Cortés YI, Shiau S, Yin MT. Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS 2014;28:2119-31. [PMID: 24977441 DOI: 10.1097/QAD.0000000000000363] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
3 Bedimo R, Maalouf NM, Lo Re V 3rd. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Curr Opin HIV AIDS 2016;11:285-93. [PMID: 26890206 DOI: 10.1097/COH.0000000000000259] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Maalouf NM, Zhang S, Drechsler H, Brown GR, Tebas P, Bedimo R. Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients. J Bone Miner Res 2013;28:2577-83. [PMID: 23677838 DOI: 10.1002/jbmr.1988] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
5 Duan XF, Fan XL. Chronic liver disease and osteoporosis. Shijie Huaren Xiaohua Zazhi 2010; 18(27): 2841-2845 [DOI: 10.11569/wcjd.v18.i27.2841] [Reference Citation Analysis]
6 Yoshikawa A, Terashita K, Morikawa K, Matsuda S, Yamamura T, Sarashina K, Nakano S, Kobayashi Y, Sogabe S, Takahashi K, Haba S, Oda H, Takahashi T, Miyagishima T, Sakamoto N. Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report. Clin J Gastroenterol 2017;10:270-3. [PMID: 28447325 DOI: 10.1007/s12328-017-0742-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
7 Bedimo R, Kang M, Tebas P, Overton ET, Hollabaugh K, McComsey G, Bhattacharya D, Evans C, Brown TT, Taiwo B. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Res Hum Retroviruses 2016;32:325-8. [PMID: 26499270 DOI: 10.1089/AID.2015.0204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Huang WH, Yu MC, Huang JY, Lai PC. Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients. PLoS One. 2013;8:e63263. [PMID: 23675468 DOI: 10.1371/journal.pone.0063263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
9 Handzlik-Orlik G, Holecki M, Wilczyński K, Duława J. Osteoporosis in liver disease: pathogenesis and management. Ther Adv Endocrinol Metab 2016;7:128-35. [PMID: 27293541 DOI: 10.1177/2042018816641351] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
10 Nagao Y, Kimura K, Kawahigashi Y, Sata M. Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals. Clin Transl Gastroenterol. 2016;7:e179. [PMID: 27388424 DOI: 10.1038/ctg.2016.37] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
11 Bihari C, Lal D, Thakur M, Sukriti S, Mathur D, Patil AG, Anand L, Kumar G, Sharma S, Thapar S, Rajbongshi A, Rastogi A, Kumar A, Sarin SK. Suboptimal Level of Bone-Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy. Hepatol Commun 2018;2:1095-110. [PMID: 30202823 DOI: 10.1002/hep4.1234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol 2011;55:770-6. [PMID: 21338640 DOI: 10.1016/j.jhep.2011.01.035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
13 Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJ. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. Am J Clin Nutr 2013;98:423-9. [PMID: 23739141 DOI: 10.3945/ajcn.112.048785] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Belle A, Gizard E, Conroy G, Lopez A, Bouvier-Alias M, Rouanet S, Peyrin-Biroulet L, Pawlotsky JM, Bronowicki JP. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients. United European Gastroenterol J 2017;5:69-75. [PMID: 28405324 DOI: 10.1177/2050640616640157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
15 Yin MT, Brown TT. HIV and Bone Complications: Understudied Populations and New Management Strategies. Curr HIV/AIDS Rep 2016;13:349-58. [PMID: 27730445 DOI: 10.1007/s11904-016-0341-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
16 Mello M, Weideman RA, Little BB, Weideman MW, Cryer B, Brown GR. Proton Pump Inhibitors Increase the Incidence of Bone Fractures in Hepatitis C Patients. Dig Dis Sci 2012;57:2416-22. [DOI: 10.1007/s10620-012-2185-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hansen AE, Omland LH, Krarup H, Obel N. Fracture risk in hepatitis C virus infected persons: Results from the DANVIR cohort study. Journal of Hepatology 2014;61:15-21. [DOI: 10.1016/j.jhep.2014.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
18 Eltayeb AA, Abdou MAA, Abdel-aal AM, Othman MH. Vitamin D status and viral response to therapy in hepatitis C infected children. World J Gastroenterol 2015; 21(4): 1284-1291 [PMID: 25632203 DOI: 10.3748/wjg.v21.i4.1284] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
19 Baeg MK, Yoon SK, Ko S, Han K, Choi HJ, Bae SH, Choi JY, Choi M. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys. Hepatol Int 2016;10:470-7. [DOI: 10.1007/s12072-015-9672-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
20 Arase Y, Kobayashi M, Kawamura Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Kobayashi T. Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C: Hemorrhagic Stroke in Chronic Hepatitis C. J Med Virol 2014;86:169-75. [DOI: 10.1002/jmv.23777] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
21 T Yin M, RoyChoudhury A, Nishiyama K, Lang T, Shah J, Olender S, Ferris DC, Zeana C, Sharma A, Zingman B, Bucovsky M, Colon I, Shane E. Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women. Osteoporos Int 2018;29:871-9. [PMID: 29387910 DOI: 10.1007/s00198-017-4354-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Brown TT, Yin MT. HIV and Osteoporosis. Osteoporosis. Elsevier; 2013. pp. 1305-29. [DOI: 10.1016/b978-0-12-415853-5.00054-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Gaudio A, Pennisi P, Muratore F, Bertino G, Ardiri A, Pulvirenti I, Tringali G, Fiore CE. Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: A peripheral quantitative computed tomography (pQCT) study. European Journal of Internal Medicine 2012;23:656-60. [DOI: 10.1016/j.ejim.2012.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]